Integra Lifesciences Holdings (IART) Change in Cash (2009 - 2026)
Integra Lifesciences Holdings (IART) posted Change in Cash of -$22.4 million for Q2 2026, down 1371.66% sequentially from $1.8 million in Q1 2026, and down 5.68% YoY from -$23.7 million in Q2 2025.
Integra Lifesciences Holdings (IART) Change in Cash (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported Change in Cash for 18 years, with the latest figure at -$22.4 million in Q2 2026.
- Quarterly Change in Cash fell 5.68% year-over-year to -$22.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$3.5 million (down 230.66% YoY) and the FY2025 annual result came in at -$11.3 million, up 62.28% from the prior year.
- Change in Cash eased to -$22.4 million in Q2 2026 per IART's latest filing, from $1.8 million in the prior quarter.
- Over five years, Change in Cash peaked at $315.5 million in Q1 2024 and troughed at -$376.7 million in Q2 2024.
- A 5-year average of -$16.6 million and a median of $841000.0 in 2024 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2024 and 2025: Change in Cash sank 20739.45% in 2024, then soared 18165.82% in 2025.
- Over 5 years, Change in Cash stood at -$55.3 million in 2022, then surged by 104.83% to $2.7 million in 2023, then soared by 1069.21% to $31.2 million in 2024, then tumbled by 90.83% to $2.9 million in 2025, then plunged by 882.46% to -$22.4 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$22.4 million, $1.8 million, and $2.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 513.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 803.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -890.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 462.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -13.20 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -180.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -1.21 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 42.80 Mn |
| 10 | Integra Lifesciences Holdings | 1.28 Bn | 1.01 Bn | 219.74 Mn | -22.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -22.39 Mn |
| Mar 31, 2026 | 1.76 Mn |
| Dec 31, 2025 | 2.86 Mn |
| Sep 30, 2025 | 14.27 Mn |
| Jun 30, 2025 | -21.19 Mn |
| Mar 31, 2025 | -7.27 Mn |
| Dec 31, 2024 | 31.22 Mn |
| Sep 30, 2024 | -79,000.00 |
| Jun 30, 2024 | -376.67 Mn |
| Mar 31, 2024 | 315.50 Mn |
| Dec 31, 2023 | 2.67 Mn |
| Sep 30, 2023 | -35.46 Mn |
| Jun 30, 2023 | 1.83 Mn |
| Mar 31, 2023 | -149.29 Mn |
| Dec 31, 2022 | -55.28 Mn |
| Sep 30, 2022 | 64.79 Mn |
| Jun 30, 2022 | 40.06 Mn |
| Mar 31, 2022 | -106.36 Mn |
| Dec 31, 2021 | 43.22 Mn |
| Sep 30, 2021 | 72.82 Mn |